Adherence to Antidepressant Treatment in Subjects With Depression

PHASE2TerminatedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

May 15, 2019

Study Completion Date

May 15, 2019

Conditions
Depression
Interventions
DRUG

Escitalopram + RT2CK17

Participants randomized to active or placebo condition will be prescribed medication over the course of 8 weeks, with in-person follow-up visits at weeks 0, 2, 4 and 8, with follow-up phone calls on weeks 1, 3 and 6.

DRUG

Escitalopram + Placebo

Participants randomized to active or placebo condition will be prescribed medication over the course of 8 weeks, with in-person follow-up visits at weeks 0, 2, 4 and 8, with follow-up phone calls on weeks 1, 3 and 6.

Trial Locations (1)

74136

Laureate Institute for Brain Research, Tulsa

All Listed Sponsors
lead

Laureate Institute for Brain Research, Inc.

OTHER